Bank of New York Mellon’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
EAM
GCP
RBI
MCP
AIP
Bank of New York Mellon's TNYA Position: Q2 2026 in Review
Bank of New York Mellon held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 24,006 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4271.
Bank of New York Mellon first reported a position in TNYA in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.18M in Q2 2023. 57 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.
- Bank of New York Mellon held 24,006 shares of Tenaya Therapeutics worth $17.7K as of Q2 2026.
- Bank of New York Mellon left its Tenaya Therapeutics share count unchanged in Q2 2026.
- Tenaya Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4271 holding.
- Bank of New York Mellon first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 17 quarters since.
- Bank of New York Mellon's Tenaya Therapeutics position peaked at $1.18M in Q2 2023.
- 57 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.